Resource Details


NICE - Guidance on the use of ribavirin and interferon alpha for Hepatitis C

Author(s)National Institute for Health and Clinical Excellence
AbstractGuidance on the use of ribavirin and interferon alpha - drugs for the treatment of patients with the hepatitis C virus. Section 1 constitutes the institute's guidance and the remainder of the document is structured in the following way: clinical need and practice, the technology, evidence, implications for the NHS, further research, implementation, clinical audit advice and review of guidance. Appendix D contains information for patients.
Patient information can be found at
Date of publishing10/01/2000
Date of last review by us10/26/2005
Bookmark this page Email this page to a friend Print this page



Twitter FeedTwitter Feed